| Ytd | -14.16% | |
| 1y | -16.18% |
| Open | 6.05 | Prev Close | 6.06 | Low | 6.04 | High | 6.05 | Mkt Cap | 553.83M |
| Vol | 494.00 | Avg Vol | 93.84K | EPS | 0.07 | P/E | 86.57 | Forward P/E | 25.22 |
| Beta | 1.89 | Short Ratio | 21.22 | Inst. Own | 1.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 6.34 | 200-d Avg | 7.37 | 1yr Est | 0.00 |
SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or